Vaishali Pharma Share Price

NSE
VAISHALI •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Vaishali Pharma
Vaishali Pharma Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Vaishali Pharma Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
New 52W Low in past week
-28.1
Dividend yield 1yr %
0

Vaishali Pharma shareholding Pattern

Promoter
26.3%
Public
73.7%
Promoter
26.3%
Public
73.7%
Promoter
26.3%
Public
73.7%
Promoter
26.3%
Public
73.7%
Promoter
26.6%
Public
73.4%
Promoter
26.6%
Public
73.4%

Vaishali Pharma Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
5
Bearish Moving Averages
11
5Day EMA
11.70
10Day EMA
12.00
12Day EMA
12.10
20Day EMA
12.70
26Day EMA
13.00
50Day EMA
14.10
100Day EMA
15.30
200Day EMA
16.00
5Day SMA
11.50
10Day SMA
12.00
20Day SMA
12.70
30Day SMA
13.50
50Day SMA
14.40
100Day SMA
16.00
150Day SMA
17.10
200Day SMA
16.80
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
1230116 Rs
2234071 Rs
Week Rs
689491 Rs
1122694 Rs
Month Rs
343545 Rs
538233 Rs
Resistance & Support
11.89
Pivot
Resistance
First Resistance
13.27
Second Resistance
13.97
Third Resistance
15.35
Support
First Support
11.19
Second support
9.81
Third Support
9.11
Relative Strength Index
46.22
Money Flow Index
33.77
MACD
-0.91
MACD Signal
-0.88
Average True Range
1.18
Average Directional Index
30.08
Rate of Change (21)
-14.01
Rate of Change (125)
-35.72

Vaishali Pharma Company background

Founded in: 2008
Managing director: Atul Vasani
Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name Vaishali Pharma Private Limited on 25th, April 2008. On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz. M/s. Vaishali Pharmachem through Business Assignment agreement. Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited. Subsequently, the Company converted into a Public Limited Company and the name was changed to Vaishali Pharma Limited on 21st, June 2017. Atul Vasani and Jagruti Vasani are the Promoters of the Company.Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal nutraceutical products. The Company is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For the export markets, the Company gets the formulations whose facilities are approved and certified by respective countries for developing the products. The Company has over 250 + formulation brands marketed in multiple countries of which dossier is in CTD format along with itsrespective bioequivalence. The Company built a robust pipeline of around 250 Dossiers. The Companys synergistic collaboration with WHOGMP manufacturing facilities is backed by an excellent rapport with clients.In 2012, the Company ventured into new Vertical in Formulation Manufacturing and Exports. In 2016, it introduced a vertical of Surgical Division. The Company obtained ISO 9001:2015 Certification for the Quality Management System from Deutsche Accreditation Board, Germany and ISC Global, Dubai, UAE. It is also certified by European Certification Organisation and Compliance Certificate with regards to Council Directive relating to Surgical Instruments Medical Devices Directive. In addition, the Company has also been recognized by Government of India as One Star Export House and holds a valid certificate for the same from the Director General of Foreign Trade in 2017. In August 2017, Company came up with an Initial Public Offer consisting of Fresh Issue of 19,76,000 Equity Shares by raising capital aggregating Rs 14.22 Crore.
Read More

Vaishali Pharma FAQs

Vaishali Pharma share price in the past 1-year return was -10.2. The Vaishali Pharma share hit a 1-year low of Rs. 10.3 and a 1-year high of Rs. 24.91.

The market cap of Vaishali Pharma is Rs. 134.85 Cr. as of 27/3/2025.

The PE ratios of Vaishali Pharma is 314.5 as of 27/3/2025.

The PB ratios of Vaishali Pharma is 2.06 as of 27/3/2025

You can easily buy Vaishali Pharma shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Vaishali Pharma stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -